Skip to main content
Type at least 3 characters

488 articles

Correction

Published on 12 Jun 2023

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

in Respiratory Pharmacology

  • Daniel Morales-Cano
  • Jose Luis Izquierdo-GarcĂ­a
  • Bianca Barreira
  • Sergio Esquivel-Ruiz
  • Maria Callejo
  • Rachele Pandolfi
  • Palmira Villa-Valverde
  • Ignacio RodrĂ­guez
  • Angel Cogolludo
  • Jesus Ruiz-Cabello
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228923
  • 1,607 views